Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
Abstract The clinical approval of platinum‐based drugs has prompted the development of novel metallo‐complexes during the last several decades, while severe problems, especially for poor water solubility, drug resistance and toxicity in patients, greatly hindered the clinical trials and curative eff...
Saved in:
| Main Authors: | Jinzhe Liang, Fangmian Wei, Hui Chao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-09-01
|
| Series: | Smart Molecules |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/smo.20240030 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Trends in Clinical Trials of Prodrugs
by: Diogo Boreski, et al.
Published: (2025-02-01) -
Metallo‐supramolecular nanofibers based on type‐I photosensitizer for synergistic antibacterial therapy
by: Shibo Lyu, et al.
Published: (2024-12-01) -
Creation of anthracycline prodrug
by: A. N. Tevyashova
Published: (2014-12-01) -
Prodrug-based bispecific antibodies for cancer therapy: advances and future directions
by: Zhijuan Ai, et al.
Published: (2025-01-01) -
Elucidation of critical chemical moieties of metallo-β-lactamase inhibitors and prioritisation of target metallo-β-lactamases
by: Jung Hun Lee, et al.
Published: (2024-12-01)